{
    "applicationNumber": "BR 11 2021 018295-0",
    "filingDate": "13/03/2020",
    "grantDate": null,
    "title": "COMPOSI\u00c7\u00d5ES E M\u00c9TODOS PARA TRATAMENTO DE C\u00c2NCER",
    "nationalPhaseDate": [
        "15/09/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2020/022743",
        "pctDate": "13/03/2020",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/819,322",
            "priorityDate": "15/03/2019"
        },
        {
            "countryCode": "US",
            "priorityNumber": "62/904,241",
            "priorityDate": "23/09/2019"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2647"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2655"
        }
    ],
    "inventors": [
        "DAVID A NATHANSON",
        "MICHAEL E JUNG",
        "JONATHAN TSANG",
        "LORENZ URNER",
        "PETER M CLARK",
        "TIMOTHY F CLOUGHESY",
        "GYUDONG KIM",
        "ROY LOBB",
        "PAUL RENNERT",
        "RICHARD PHILIPSON",
        "SEPPO YLA"
    ],
    "holders": [
        304065,
        213847,
        23919
    ],
    "ipcCodes": [
        "A61P 35/00",
        "A61K 38/17",
        "A61K 31/70",
        "C12N 15/86"
    ]
}